(Q54937011)

English

OVCAR-5

cell line

OVCAR 5
NIH:OVCAR-5
OVCAR.5
OVCAR5
OVCA5

In more languages

Statements

1 reference

Cellosaurus release 44

27 January 2023

cancer cell line

1 reference

Cellosaurus release 44

27 January 2023

contaminated/misidentified cell line

1 reference

Cellosaurus release 44

27 January 2023

described by source

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

Cellosaurus release 44

27 January 2023

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

1 reference

Cellosaurus release 44

27 January 2023

Characterization of immunotoxins active against ovarian cancer cell lines

1 reference

Cellosaurus release 44

27 January 2023

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines

1 reference

Cellosaurus release 44

27 January 2023

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

Cellosaurus release 44

27 January 2023

Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers

1 reference

Cellosaurus release 44

27 January 2023

Gene expression patterns in ovarian carcinomas

1 reference

Cellosaurus release 44

27 January 2023

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

1 reference

Cellosaurus release 44

27 January 2023

DNA fingerprinting of the NCI-60 cell line panel

1 reference

Cellosaurus release 44

27 January 2023

Genomic complexity and AKT dependence in serous ovarian cancer

1 reference

Cellosaurus release 44

27 January 2023

JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs

1 reference

Cellosaurus release 44

27 January 2023

Identification of cancer cell-line origins using fluorescence image-based phenomic screening

1 reference

Cellosaurus release 44

27 January 2023

Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

1 reference

Cellosaurus release 44

27 January 2023

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

1 reference

Cellosaurus release 44

27 January 2023

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

1 reference

Cellosaurus release 44

27 January 2023

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

1 reference

Cellosaurus release 44

27 January 2023

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

1 reference

Cellosaurus release 44

27 January 2023

Global proteome analysis of the NCI-60 cell line panel

1 reference

Cellosaurus release 44

27 January 2023

Type-specific cell line models for type-specific ovarian cancer research

1 reference

Cellosaurus release 44

27 January 2023

The metabolic demands of cancer cells are coupled to their size and protein synthesis rates

1 reference

Cellosaurus release 44

27 January 2023

In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome

1 reference

Cellosaurus release 44

27 January 2023

High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner

1 reference

Cellosaurus release 44

27 January 2023

A comprehensive transcriptional portrait of human cancer cell lines

1 reference

Cellosaurus release 44

27 January 2023

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

1 reference

Cellosaurus release 44

27 January 2023

Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line

1 reference

Cellosaurus release 44

27 January 2023

Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR

1 reference

Cellosaurus release 44

27 January 2023

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 44

27 January 2023

Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status

1 reference

Cellosaurus release 44

27 January 2023

A map of mobile DNA insertions in the NCI-60 human cancer cell panel.

1 reference

Cellosaurus release 44

27 January 2023

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 44

27 January 2023

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

Cellosaurus release 44

27 January 2023

Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches

1 reference

Cellosaurus release 44

27 January 2023

HLA class I and II genotype of the NCI-60 cell lines

1 reference

Cellosaurus release 44

27 January 2023

Signatures of mutation and selection in the cancer genome

1 reference

Cellosaurus release 44

27 January 2023

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

1 reference

Cellosaurus release 44

27 January 2023

Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer

1 reference

Cellosaurus release 44

27 January 2023

Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines

1 reference

Cellosaurus release 44

27 January 2023

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 44

27 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 44

27 January 2023

Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer

1 reference

Cellosaurus release 44

27 January 2023

S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival

1 reference

Cellosaurus release 44

27 January 2023

Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities

1 reference

Cellosaurus release 44

27 January 2023

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

1 reference

Cellosaurus release 44

27 January 2023

established from medical condition

high grade ovarian serous adenocarcinoma

1 reference

Cellosaurus release 44

27 January 2023

derived from organism type

1 reference

Cellosaurus release 44

27 January 2023

http://purl.obolibrary.org/obo/BTO_0001870

1 reference

Cellosaurus release 44

27 January 2023

http://purl.obolibrary.org/obo/EFO_0005443

1 reference

Cellosaurus release 44

27 January 2023

http://purl.obolibrary.org/obo/CLO_0008280

1 reference

Cellosaurus release 44

27 January 2023

Identifiers

Cell Line Ontology ID

1 reference

Cellosaurus release 44

27 January 2023

1 reference

Cellosaurus release 44

27 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54937011&oldid=1861684327"